SLC5A2 and hydrops fetalis: A recent meta‐analysis confirmed that early administration of SGLT2 inhibitors in the AHF setting leads to a significant risk reduction of 62% in HF events, defined as a recurrent HF hospitalization/emergency department admissions, urgent care visits, or the need for intensification of management during outpatient follow‐up consultations.31